539 related articles for article (PubMed ID: 23266328)
21. Desmopressin acetate (DDAVP)-associated hyponatremia and brain damage: a case series.
Achinger SG; Arieff AI; Kalantar-Zadeh K; Ayus JC
Nephrol Dial Transplant; 2014 Dec; 29(12):2310-5. PubMed ID: 25107337
[TBL] [Abstract][Full Text] [Related]
22. Hyponatremia and hypernatremia: disorders of water balance.
Agrawal V; Agarwal M; Joshi SR; Ghosh AK
J Assoc Physicians India; 2008 Dec; 56():956-64. PubMed ID: 19322975
[TBL] [Abstract][Full Text] [Related]
23. Hypertonic Saline for Hyponatremia: Meeting Goals and Avoiding Harm.
Rondon-Berrios H; Sterns RH
Am J Kidney Dis; 2022 Jun; 79(6):890-896. PubMed ID: 34508830
[TBL] [Abstract][Full Text] [Related]
24. A low initial serum sodium level is associated with an increased risk of overcorrection in patients with chronic profound hyponatremia: a retrospective cohort analysis.
Aratani S; Hara M; Nagahama M; Taki F; Futatsuyama M; Tsuruoka S; Komatsu Y
BMC Nephrol; 2017 Oct; 18(1):316. PubMed ID: 29047375
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic relowering of the serum sodium in a patient after excessive correction of hyponatremia.
Soupart A; Ngassa M; Decaux G
Clin Nephrol; 1999 Jun; 51(6):383-6. PubMed ID: 10404700
[TBL] [Abstract][Full Text] [Related]
26. Management of severe hyponatremia: infusion of hypertonic saline and desmopressin or infusion of vasopressin inhibitors?
Tzamaloukas AH; Shapiro JI; Raj DS; Murata GH; Glew RH; Malhotra D
Am J Med Sci; 2014 Nov; 348(5):432-9. PubMed ID: 25247759
[TBL] [Abstract][Full Text] [Related]
27. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
28. Treating desmopressin-induced hyponatremia: a case using hypertonic saline.
Shirazian S; Ali N; Fishbane S
Clin Nephrol; 2013 Nov; 80(5):385-7. PubMed ID: 22579272
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of rapid intermittent correction compared with slow continuous correction with hypertonic saline in patients with moderately severe or severe symptomatic hyponatremia: study protocol for a randomized controlled trial (SALSA trial).
Lee A; Jo YH; Kim K; Ahn S; Oh YK; Lee H; Shin J; Chin HJ; Na KY; Lee JB; Baek SH; Kim S
Trials; 2017 Mar; 18(1):147. PubMed ID: 28356136
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of a protocol for hypertonic saline administration in acute euvolemic symptomatic hyponatremia: A prospective observational trial.
Bhaskar E; Kumar B; Ramalakshmi S
Indian J Crit Care Med; 2010 Oct; 14(4):170-4. PubMed ID: 21572746
[TBL] [Abstract][Full Text] [Related]
31. Treatment of symptomatic hyponatremia.
Decaux G; Soupart A
Am J Med Sci; 2003 Jul; 326(1):25-30. PubMed ID: 12861122
[TBL] [Abstract][Full Text] [Related]
32. Treatment of hyponatremic encephalopathy with a 3% sodium chloride protocol: a case series.
Ayus JC; Caputo D; Bazerque F; Heguilen R; Gonzalez CD; Moritz ML
Am J Kidney Dis; 2015 Mar; 65(3):435-42. PubMed ID: 25465163
[TBL] [Abstract][Full Text] [Related]
33. Current treatment practice and outcomes. Report of the hyponatremia registry.
Greenberg A; Verbalis JG; Amin AN; Burst VR; Chiodo JA; Chiong JR; Dasta JF; Friend KE; Hauptman PJ; Peri A; Sigal SH
Kidney Int; 2015 Jul; 88(1):167-77. PubMed ID: 25671764
[TBL] [Abstract][Full Text] [Related]
34. Thiazide-Associated Hyponatremia, Report of the Hyponatremia Registry: An Observational Multicenter International Study.
Burst V; Grundmann F; Kubacki T; Greenberg A; Becker I; Rudolf D; Verbalis J
Am J Nephrol; 2017; 45(5):420-430. PubMed ID: 28419981
[TBL] [Abstract][Full Text] [Related]
35. DDAVP to prevent rapid correction in hyponatremia.
Goldszmidt MA; Iliescu EA
Clin Nephrol; 2000 Mar; 53(3):226-9. PubMed ID: 10749304
[TBL] [Abstract][Full Text] [Related]
36. Diagnosing and Treating the Syndrome of Inappropriate Antidiuretic Hormone Secretion.
Verbalis JG; Greenberg A; Burst V; Haymann JP; Johannsson G; Peri A; Poch E; Chiodo JA; Dave J
Am J Med; 2016 May; 129(5):537.e9-537.e23. PubMed ID: 26584969
[TBL] [Abstract][Full Text] [Related]
37. Risk Factors and Outcomes of Rapid Correction of Severe Hyponatremia.
George JC; Zafar W; Bucaloiu ID; Chang AR
Clin J Am Soc Nephrol; 2018 Jul; 13(7):984-992. PubMed ID: 29871886
[TBL] [Abstract][Full Text] [Related]
38. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia.
Perianayagam A; Sterns RH; Silver SM; Grieff M; Mayo R; Hix J; Kouides R
Clin J Am Soc Nephrol; 2008 Mar; 3(2):331-6. PubMed ID: 18235152
[TBL] [Abstract][Full Text] [Related]
39. [Hyponatremia secondary to inappropriate antidiuretic hormone secretion].
Zamboli P; De Nicola L; Minutolo R; Iodice C; Avino D; Mascia S; D'Angiò P; Calabria M; Conte G
G Ital Nefrol; 2008; 25(5):554-61. PubMed ID: 18985840
[TBL] [Abstract][Full Text] [Related]
40. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
